In pancreatic cancer (PCC) cells, FBW7 promoted gemcitabine sensitivity via upregulation of equilibrative nucleoside transporter 1 (ENT1) through lysosome inhibition (Hu et al., 2017). The gene discussed is SLC29A1; the disease is familial pancreatic carcinoma.